SCHEMBL1839728

SCHEMBL1839728

COc1nc2nc(OC(C)C)[nH]c(N)c-2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1919728 0.83 MCHR1 (0.33)
Trifluoroacetic Acid SCHEMBL2202675 0.74 S1PR4 (0.30)
SCHEMBL14804671 0.62 ALDH1A1 (0.38)
SCHEMBL21318822 0.62 ALDH1A1 (0.38)
SCHEMBL10121645 0.56 ADORA2A (0.31)
SCHEMBL32687993 0.55 CYP1A2 (0.41)
SCHEMBL12757466 0.54 LMNA (0.47)
SCHEMBL21543540 0.54 ALDH1A1 (0.35)
SCHEMBL33145 0.53 ALDH1A1 (0.43)
SCHEMBL18287434 0.53 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246030-A1 NOVEL ADENINE DERIVATIVES GlaxoSmithKline LLC (US) 2017-11-22 EP disclosed
EP-2320905-B1 NOVEL ADENINE DERIVATIVES GLAXOSMITHKLINE LLC (US) 2017-06-28 EP disclosed
US-8802684-B2 Adenine derivatives GLAXOSMITHKLINE LLC (US) 2014-08-12 US disclosed
US-20140024664-A1 NOVEL ADENINE DERIVATIVES GLAXOSMITHKLINE LLC (US) 2014-01-23 US disclosed
US-8563717-B2 Adenine derivatives GLAXOSMITHKLINE LLC (US) 2013-10-22 US disclosed
US-20110144136-A1 NOVEL ADENINE DERIVATIVES GLAXOSMITHKLINE LLC (US) 2011-06-16 US disclosed
EP-2320905-A1 NOVEL ADENINE DERIVATIVES Smithkline Beecham Corporation (US) 2011-05-18 EP disclosed
WO-2010018134-A1 NOVEL ADENINE DERIVATIVES SMITHKLINE BEECHAM CORPORATION (US) 2010-02-18 WO disclosed